Tarsus Pharmaceuticals Inc (TARS) Insider Trading
- $8,575,268.80
- $27,654,139.47
- March 18, 2024
- Bobak R Azamian
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 18, 2024 | General Counsel | 4,436 | $30.60 | Sell | $135,741.60 | |
March 18, 2024 | Insider | 4,766 | $30.60 | Sell | $145,839.60 | |
March 18, 2024 | CEO | 10,415 | $30.60 | Sell | $318,699.00 | |
March 18, 2024 | COO | 4,879 | $30.60 | Sell | $149,297.40 | |
Dec. 27, 2023 | CEO | 8,000 | $20.22 | Sell | $161,760.00 | |
Dec. 20, 2023 | CEO | 40,000 | $20.27 | Sell | $810,800.00 | |
Dec. 20, 2023 | Insider | 2,252 | $20.00 | Sell | $45,040.00 | |
Dec. 15, 2023 | Director | 1,000 | $18.96 | Buy | $18,960.00 | |
Nov. 30, 2023 | General Counsel | 8,356 | $16.31 | Sell | $136,286.36 | |
Nov. 30, 2023 | Insider | 8,355 | $16.31 | Sell | $136,270.05 | |
Oct. 18, 2023 | CEO | 8,000 | $13.24 | Sell | $105,920.00 | |
Oct. 5, 2023 | Insider | 1,604 | $18.00 | Sell | $28,872.00 | |
Sept. 20, 2023 | CEO | 8,000 | $17.21 | Sell | $137,680.00 | |
Aug. 23, 2023 | CEO | 8,000 | $17.23 | Sell | $137,840.00 | |
Aug. 15, 2023 | Director | 9,506 | $16.80 | Buy | $159,700.80 | |
July 19, 2023 | CEO | 103,900 | $20.01 | Sell | $2,079,039.00 | |
July 19, 2023 | Insider | 2,400 | $20.05 | Sell | $48,120.00 | |
July 12, 2023 | CEO | 9,000 | $17.35 | Sell | $156,150.00 | |
June 21, 2023 | CEO | 8,000 | $18.63 | Sell | $149,040.00 | |
June 14, 2023 | CEO | 9,000 | $18.58 | Sell | $167,220.00 | |
June 8, 2023 | CEO | 3,100 | $20.01 | Sell | $62,031.00 | |
June 8, 2023 | Insider | 100 | $20.00 | Sell | $2,000.00 | |
June 6, 2023 | Insider | 2,143 | $18.61 | Sell | $39,881.23 | |
May 17, 2023 | CEO | 8,000 | $15.90 | Sell | $127,200.00 | |
May 10, 2023 | CEO | 9,000 | $16.80 | Sell | $151,200.00 | |
May 1, 2023 | CEO | 5,841 | $15.10 | Sell | $88,199.10 | |
April 28, 2023 | CEO | 4,278 | $15.13 | Sell | $64,726.14 | |
April 21, 2023 | CEO | 2,311 | $15.03 | Sell | $34,734.33 | |
April 20, 2023 | CFO | 5,000 | $14.02 | Sell | $70,100.00 | |
April 19, 2023 | CEO | 8,000 | $13.60 | Sell | $108,800.00 | |
March 22, 2023 | Insider | 529 | $12.64 | Sell | $6,686.56 | |
March 22, 2023 | COO | 379 | $12.64 | Sell | $4,790.56 | |
March 22, 2023 | CEO | 709 | $12.64 | Sell | $8,961.76 | |
March 22, 2023 | General Counsel | 357 | $12.64 | Sell | $4,512.48 | |
March 22, 2023 | CFO | 332 | $12.64 | Sell | $4,196.48 | |
March 20, 2023 | COO | 380 | $12.61 | Sell | $4,791.80 | |
March 20, 2023 | General Counsel | 357 | $12.61 | Sell | $4,501.77 | |
March 20, 2023 | CEO | 741 | $12.61 | Sell | $9,344.01 | |
March 20, 2023 | Insider | 530 | $12.61 | Sell | $6,683.30 | |
March 20, 2023 | VP | 198 | $12.61 | Sell | $2,496.78 | |
March 20, 2023 | CFO | 333 | $12.61 | Sell | $4,199.13 | |
March 17, 2023 | CEO | 795 | $13.28 | Sell | $10,557.60 | |
March 16, 2023 | COO | 357 | $13.43 | Sell | $4,794.51 | |
March 16, 2023 | VP | 187 | $13.43 | Sell | $2,511.41 | |
March 16, 2023 | CFO | 5,313 | $13.44 | Sell | $71,406.72 | |
March 16, 2023 | Insider | 313 | $13.43 | Sell | $4,203.59 | |
March 16, 2023 | General Counsel | 337 | $13.43 | Sell | $4,525.91 | |
March 15, 2023 | CEO | 8,000 | $13.79 | Sell | $110,320.00 | |
March 8, 2023 | CEO | 4,853 | $15.02 | Sell | $72,892.06 | |
Feb. 8, 2023 | CEO | 9,000 | $15.14 | Sell | $136,260.00 |
Insiders are both buying and selling Tarsus Pharmaceuticals Inc stock.
The insider traders at Tarsus Pharmaceuticals Inc are: Bobak R Azamian, Michael Ackermann, Aziz Mottiwala, Leonard M Greenstein, Vivo Capital Ix, Llc, Bryan Wahl, Jose M Trevejo, Dianne C Whitfield, Seshadri Neervannan, Mark J Holdbrook, Elizabeth Yeu Lin, Bobak R. Azamian, Vivo Capital Fund Ix, L.P., Andrew D Goldberg, Rtw Investments, Lp, and Jason E Tester
The most active insider trader at Tarsus Pharmaceuticals Inc is Bobak R Azamian with 40 trades.
Rtw Investments, Lp has sold the most Tarsus Pharmaceuticals Inc stock with a total value of $26,982,000.00.
Vivo Capital Fund Ix, L.P. has bought the most Tarsus Pharmaceuticals Inc stock with a total value of $8,000,000.00.
The most recent insider trade for Tarsus Pharmaceuticals Inc was on March 18, 2024.
The single biggest insider buy for Tarsus Pharmaceuticals Inc was from Vivo Capital Fund Ix, L.P. with a total value of $4,000,000.00 on Oct. 20, 2020.
The single biggest insider sell for Tarsus Pharmaceuticals Inc was from Rtw Investments, Lp with a total value of $13,491,000.00 on May 7, 2021.